
🇵🇪 MD @CayetanoHeredia | Research Scholar at @UAB_NRTC | Aspiring to IM and nephrology 🐿️ | Evidence based medicine🔬| Feminist | she/her #medtwitter
Lima, Peru
Joined April 2021
- Tweets467
- Following609
- Followers189
- Likes1K
Natalia Nombera Aznaran retweeted
Don´t miss our poster in IDWeek 2026!
@AAPPHealth @pams_web
Natalia Nombera Aznaran retweeted
Excited to share our new paper in DIGITAL HEALTH! 🧠📊
“Structured reasoning frameworks in nephrology graphical abstracts and their interpretation by vision-capable large language models”
We explored how the visual organization of nephrology graphical abstracts relates to AI’s understanding of their scientific message.
Grateful to Dr. Cheungpasitporn @wisit661 for his mentorship, our wonderful coauthors for their collaboration, and Mayo Clinic Nephrology @MayoClinicNeph @MayoClinic @MayoMedEd for the many opportunities to learn and grow! 🙏
doi.org/10.1177/205520762615…
Natalia Nombera Aznaran retweeted
So much energy in one room! 🔥🙌🏽
Amazing to see so many Latinos coming together at #ACG2026 in Nashville! 💙
Huge thanks to Dr. @jorgemachicado for his leadership and to the @AmCollegeGastro helping make this gathering possible!
#LatinosInGI #ACG2026
Natalia Nombera Aznaran retweeted
🚨Nuestro nuevo Artículo Original🚨
En enfermedad renal crónica avanzada, el inicio urgente de diálisis peritoneal, comparado a hemodiálisis; es similar corrigiendo la acidosis metabólica
Gratis 👇🏻
Kidney360 2026
ovid.com/jnls/kidney360/full…
Udeme Ekrikpo, MD, PhD was featured as this month’s Trainee Spotlight in the KUHR-TN Newsletter!
Dr. Ekrikpo has graduated from the TL1 program and is now completing his residency at Cape Fear Valley Medical Center. We wish him the best of luck in this next chapter! @UAB_NRTC
Natalia Nombera Aznaran retweeted
bioRxiv has a dedicated section for negative results.
Use it.
Share negative results.
Your colleagues will appreciate it.
Natalia Nombera Aznaran retweeted
New in @JAMA_current : "Prediction Utility of Urinary Albumin-Creatinine vs Protein-Creatinine Ratios in Chronic Kidney Disease"
jamanetwork.com/journals/jam… @waikarss @SophieClaudel @bu_bmc_renal @The_BMC @BUMedicine
🧵👇
Natalia Nombera Aznaran retweeted
Hi #MedTwitter!
I’m Javier, an IMG from Peru 🇵🇪, applying to #InternalMedicine this #Match2027!🇺🇸
Passionate about Clinical Research & MedEd. Beyond medicine, I love guitar🎸& soccer⚽.
Excited to connect with programs and future colleagues! Wishing everyone a great season!
Natalia Nombera Aznaran retweeted
Great session tonight with Latinos in GI! 🎉
Mock interviews, practical feedback, and mentorship to help residents prepare for interview season.
Huge thanks to our faculty, fellows, and participants for making it possible! 💙 #LatinosInGI
Natalia Nombera Aznaran retweeted
Hello NephJC community,
NephJC is now over a dozen years old.
When we started, the idea was pretty simple: get a bunch of nephrologists together on Twitter, pick an important paper, and argue about it in public.
Somehow, that turned into something much bigger.
NephJC became a place where nephrologists, fellows, residents, students, researchers, and patients could come together to understand the research and manuscripts moving nephrology forward. We built detailed article summaries, visual abstracts, podcasts, book clubs, tweetorials, and an internship designed to train the next generation of medical educators.
And through all of it, we have tried to hold onto one basic principle:
The education should be free.
No subscriptions.
No passwords.
No paywalls.
And no pharmaceutical sponsorship.
Every year, big (and small) pharma offers to sponsor NephJC, or advertise at NephJC.com, or place an ad in @FreelyFiltered. It would make running NephJC much easier.
We say no.
In fact, our bylaws prevent us from accepting pharmaceutical support. Why? Because NephJC exists to critically evaluate the medical literature, including papers studying drugs made by those same companies. We believe accepting any support would at the very least create the perception of a conflict even if our hearts stayed true (which of course they would).
That’s the hill we will die on.
But independence isn’t free.
Web hosting costs money. Podcasting costs money. Software costs money. Visual abstracts cost money. Running the NephJC Editorial Internship costs money. Keeping this entire unique experiment in post-publication peer review alive costs money.
Over the years, we have funded NephJC in a lot of different ways. In the beginning, we passed the hat among the NephJC workgroup. Satellite Healthcare (RIP😢) was an early supporter. @ArkanaLabs gave us a generous three-year unrestricted grant. The Flozinator Pin (Flozinator.com) helped carry us through the pandemic.
But for the last five years we have a simple model: NephJC is supported by the people who use NephJC.
Wikipedia.
Public radio.
NephJC.
You don’t need to donate to read a NephJC summary. You don’t need to donate to download a visual abstract. You don’t need to donate to listen to Freely Filtered or Channel Your Enthusiasm. And we are never going to put those things behind a paywall.
But if NephJC has taught you something…
If one of our summaries helped you understand a paper…
If you’ve borrowed one of our visual abstracts for a lecture…
If you’ve listened to the Filtrate argue about a trial while driving to work…
If you’ve used NephJC to teach your fellows, residents, or students…
Then we’re asking you to help pay for it.
Not because you have to.
Because that’s how we keep it independent.
The alternative is easy. There is plenty of industry money available in nephrology.
We choose the harder path because we think independent, critical, open medical education is worth protecting.
If you agree, please support the 2026 NephJC Pledge Drive.
Open your wallet. Open your purse. Skip one fancy coffee. Or give enough to buy us the whole coffee shop.
Whatever makes sense for you.
Thousands of people use NephJC. We don’t need every one of them to give a lot.
We just need enough of them to give something.
Keep the FOAMed flowing. Support NephJC.
DONATE HERE: nephjc.com/news/2026/9/8/nep…
Joel Topf
President, NephJC
Natalia Nombera Aznaran retweeted
📢 Registration is NOW OPEN!
Join us for the Interview Skills Workshop on Monday, September 14 at 8:00 PM ET.
💩 Limited spots available!
✅ Completely FREE
🔗 Register here: forms.gle/E73bmymFaT61AQMi7
🤖 Made with AI
Natalia Nombera Aznaran retweeted
CRRT 2026 is in the books! Hope all the attendees learned some strategies to take back to their institutions and continue to grow their own CRRT programs
Natalia Nombera Aznaran retweeted
Awesome faculty and teachers here in Birmingham at the UAB CRRT Academy 2026 #uabcrrt2026
Natalia Nombera Aznaran retweeted
Super excited to share that our paper on rasburicase for tumor lysis syndrome is now out in @bmj_latest. Using target trial emulation and data from 36 U.S. sites, we found a major mortality benefit with early rasburicase. bmj.com/content/394/bmj-2026…
LATAM-AKID registry: an international multicentre, observational study of acute kidney injury requiring dialysis in Latin America. A protocol by @AqURehman, @roxnonna23, @javo_neyra et al. bit.ly/4vJo2lp
Natalia Nombera Aznaran retweeted
Prevalence Of CKD Among Adults in Africa: A Systematic Review and Meta-Analysis
bit.ly/4tK1S0A #OpenAccess
@SradhaKotwal @SFatumo @JuneF_sa @MRCza @UAlbertaNeph @georgeinstitute
Natalia Nombera Aznaran retweeted
In >531,000 ICU admissions, CKD was present in 25% and progressively associated with higher mortality, longer ICU/hospital stays, and sharply rising dialysis dependence.
Notably, mortality was lower in maintenance dialysis than non-dialysis CKD G5.
🔗 jamanetwork.com/journals/jam…
Natalia Nombera Aznaran retweeted
Modelo de inteligencia artificial logra predecir la trayectoria de creatinina y gasto urinario en diferentes momentos durante la hospitalización en la terapia intensiva, con certeza de 77%
Critical Care 2026
doi.org/10.1186/s13054-026-0…
Natalia Nombera Aznaran retweeted
✨Exciting news #Nephtwitter
The new #NephJC editorial interns are here!
📢 Give them a follow and make them feel at home nephjc.com/news/2025/6/21/ne…
@DrBarbaTeba @AncaSt13 @dany_rcal @kiddo_kidney @AndrewDelaat @farahwehbe92 @rn_flex @assad_sm
@ManoleaA @Nihal_Hamary



































